http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2014137109-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2840-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-50 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0066 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-117 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-68 |
| filingDate | 2013-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2014137109-A |
| titleOfInvention | NUCLEIC ACID CONTAINING OR CODING THE STRUCTURE-HINGE STRUCTURE OF HISTONS AND THE FIELD SEQUENCE (A) OR THE POLYADENYLATION SIGNAL TO INCREASE EXPRESSED CODER IS BODY |
| abstract | 1. A nucleic acid sequence containing or encoding: a) a coding region encoding at least one peptide or protein; b) at least one histone stem-loop structure, c) a poly (A) sequence or polyadenylation signal; where said peptide or protein contains a therapeutic protein or a fragment, variant or derivative thereof selected from: (i) therapeutic proteins used to treat metabolic or endocrine disorders; (ii) therapeutic proteins used to treat blood disorders, abnormalities of the cardiovascular system, respiratory system diseases, cancer or tumor diseases, infectious diseases or immunodeficiencies; (iii) therapeutic proteins used for hormone replacement therapy; (iv) therapeutic proteins used to reprogram somatic cells into pluri- or omnipotent stem cells; (v) therapeutic proteins selected from adjuvant or immunostimulatory proteins; and (vi) antibodies. 2. The nucleic acid sequence of claim 1, wherein the at least one histone stem loop loop is heterologous with respect to a coding region encoding at least one peptide or protein, where the coding region should preferably not encode a histone protein or fragment thereof , a derivative or variant performing the function of a histone or histone-like function. 3. The nucleic acid sequence according to claim 1 or 2, wherein the peptide or protein encoded by the coding region contains a therapeutic protein or fragment thereof, a variant or derivative, where a fragment, variant or derivative of a therapeutic protein stores m |
| priorityDate | 2012-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 133.